These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8463894)
1. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. Murphy TV; Pastor P; Medley F; Osterholm MT; Granoff DM J Pediatr; 1993 Apr; 122(4):517-23. PubMed ID: 8463894 [TBL] [Abstract][Full Text] [Related]
2. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. Murphy TV; White KE; Pastor P; Gabriel L; Medley F; Granoff DM; Osterholm MT JAMA; 1993 Jan; 269(2):246-8. PubMed ID: 8417244 [TBL] [Abstract][Full Text] [Related]
3. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group. Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474 [TBL] [Abstract][Full Text] [Related]
5. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Mohle-Boetani JC; Ajello G; Breneman E; Deaver KA; Harvey C; Plikaytis BD; Farley MM; Stephens DS; Wenger JD Pediatr Infect Dis J; 1993 Jul; 12(7):589-93. PubMed ID: 8346003 [TBL] [Abstract][Full Text] [Related]
6. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Takala AK; Eskola J; Leinonen M; Käyhty H; Nissinen A; Pekkanen E; Mäkelä PH J Infect Dis; 1991 Nov; 164(5):982-6. PubMed ID: 1940479 [TBL] [Abstract][Full Text] [Related]
7. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age. Hay JW; Daum RS Pediatr Infect Dis J; 1990 Apr; 9(4):246-52. PubMed ID: 2110651 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease. Rubin LG; Voulalas D; Carmody L Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group. Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080 [TBL] [Abstract][Full Text] [Related]
10. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK; Daum RS Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age. Loughlin AM; Marchant CD; Lett S; Shapiro ED Pediatr Infect Dis J; 1992 May; 11(5):374-9. PubMed ID: 1630857 [TBL] [Abstract][Full Text] [Related]
12. Finnish efficacy trials with Haemophilus influenzae type b vaccines. Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148 [TBL] [Abstract][Full Text] [Related]
13. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease. Weinberg GA; Murphy TV; Granoff DM Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629 [No Abstract] [Full Text] [Related]
14. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older. Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212 [TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]
16. Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines. Rothstein EP; Madore DV; Girone JA; Schiller RP; Hipp TJ; Souder RL; Bernstein HH Pediatr Infect Dis J; 1991 Apr; 10(4):311-4. PubMed ID: 2062627 [TBL] [Abstract][Full Text] [Related]
17. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Booy R; Heath PT; Slack MP; Begg N; Moxon ER Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study Group. Mühlemann K; Alexander ER; Weiss NS; Pepe M; Schopfer K Int J Epidemiol; 1996 Dec; 25(6):1280-5. PubMed ID: 9027536 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid-conjugate vaccine. Nelson WL; Granoff DM Am J Dis Child; 1990 Mar; 144(3):292-5. PubMed ID: 2305734 [TBL] [Abstract][Full Text] [Related]
20. Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine. Frasch CE; Hiner EE; Gross TP Am J Dis Child; 1991 Dec; 145(12):1379-82. PubMed ID: 1669664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]